Findings show the impact of drug companies’ relentless price increases, underscoring the importance of the changes included ...

Plans for the second Trump administration, state EPR implementation, climate policy and PFAS regulation are evolving, as is landfill monitoring technology. Here’s how each could affect the industry in ...

Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...

The EV tax credit, designed to help America lead in one of the world’s fastest-growing markets, should be preserved.

Warner and Tim Kaine (both D-VA) recently celebrated a provision of the Inflation Reduction Act that will go into effect on January 1, 2025 to cap out-of-pocket costs for prescription drugs at $2,000 ...

The U.S. Department of Energy Bioenergy Technologies Office and the U.S. Environmental Protection Agency announced $6 MM in funding for three projects that will advance biofuel development and support ...

In a twist of fate, I was advocating for accessible health care when I first felt pain in my left breast. Like many women, ...

Enrollment in the Affordable Care Act (ACA) marketplace has surged to a record high, but AM Best has reported that the White ...

Donald Trump told reporters Tuesday he wants to halt wind farming. Wyoming Sen. Cale Case generally agrees, saying the market ...

US greenhouse gas emissions barely decreased in 2024, leaving the world's largest economy off track to achieve its climate goals, according to an analysis released Thursday, as the incoming Trump ...

The Biden administration’s justification of the first cycle of Medicare drug price negotiations is fueling curiosity and ...

Novo Nordisk expects Ozempic, which has been on the market since 2017, will be on Medicare's list of drugs to negotiate prices concessions, Bloomberg reported. The company told USA TODAY that it would ...